Barbara J Stegmann
Overview
Explore the profile of Barbara J Stegmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
534
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shankar R, Shah S, Joeng H, Mendizabal G, DiBello J, Guan Y, et al.
J Clin Endocrinol Metab
. 2022 Mar;
107(7):2036-2046.
PMID: 35275602
Context: Adolescent males with hypogonadotropic hypogonadism (HH) have traditionally been treated with exogenous testosterone (T) or human chorionic gonadotropin (hCG) to produce virilization; however, those modalities do not result in...
2.
Nieschlag E, Bouloux P, Stegmann B, Shankar R, Guan Y, Tzontcheva A, et al.
Reprod Biol Endocrinol
. 2017 Mar;
15(1):17.
PMID: 28270212
Background: Hypogonadotropic hypogonadism (HH) in men results in insufficient testicular function and deficiencies in testosterone and spermatogenesis. Combinations of human chorionic gonadotropin (hCG) and recombinant follicle-stimulating hormone (recFSH) have been...
3.
Griesinger G, Boostanfar R, Gordon K, Gates D, McCrary Sisk C, Stegmann B
Reprod Biomed Online
. 2016 May;
33(1):56-60.
PMID: 27178762
A meta-analysis was conducted of individual patient data (n = 3292) from three randomized controlled trials of corifollitropin alfa versus rFSH: Engage (150 µg corifollitropin alfa n = 756; 200 ...
4.
Boostanfar R, Gates D, Guan Y, Gordon K, McCrary Sisk C, Stegmann B
Fertil Steril
. 2016 Apr;
106(2):300-305.e5.
PMID: 27090863
Objective: To examine the efficacy and safety of frozen-thawed embryo transfer (FTET) cycles with supernumerary embryos cryopreserved during a randomized clinical trial (PURSUE). Design: Follow-up clinical study. Setting: In vitro...
5.
Zandvliet A, Prohn M, de Greef R, van Aarle F, McCrary Sisk C, Stegmann B
Br J Clin Pharmacol
. 2016 Mar;
82(1):74-82.
PMID: 26991902
Aim: The aim of the present study was to characterize the pharmacokinetic profile of corifollitropin alfa and examine the relationships between dose, intrinsic factors [body weight, body mass index (BMI),...
6.
Griesinger G, Verweij P, Gates D, Devroey P, Gordon K, Stegmann B, et al.
PLoS One
. 2016 Mar;
11(3):e0149615.
PMID: 26950065
Study Question: What is the threshold for the prediction of moderate to severe or severe ovarian hyperstimulation syndrome (OHSS) based on the number of growing follicles ≥ 11 mm and/or...
7.
Oehninger S, Nelson S, Verweij P, Stegmann B
Reprod Biol Endocrinol
. 2015 Nov;
13:117.
PMID: 26520396
Background: This secondary analysis aimed to identify predictors of low (<6 oocytes retrieved) and high ovarian response (>18 oocytes retrieved) in IVF patients undergoing controlled ovarian stimulation with corifollitropin alfa...
8.
Stegmann B, Santillan M, Leader B, Smith E, Santillan D
Fertil Steril
. 2015 Jun;
104(2):347-55.e3.
PMID: 26074093
Objective: To determine the association of preterm birth with antimüllerian hormone (AMH) levels both in isolation and in combination with other markers of fetoplacental health commonly measured during integrated prenatal...
9.
Boostanfar R, Shapiro B, Levy M, Rosenwaks Z, Witjes H, Stegmann B, et al.
Fertil Steril
. 2015 May;
104(1):94-103.e1.
PMID: 26003273
Objective: To compare corifollitropin alfa with recombinant FSH treatment in terms of the vital pregnancy rate in older patients undergoing IVF. Design: Phase 3 randomized, double-blind, noninferiority trial. Setting: Multicenter...
10.